NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Anthropic PBC Designated as Supply Chain Risk by United States Department of War

Anthropic PBC, an artificial intelligence company, has been formally designated as a Supply Chain Risk (SCR) by the United States Department of War (DoW).

Key Developments

  • On 4 March, Anthropic CEO Dario Amodei received a letter from the DoW confirming the designation.
  • Anthropic has stated that it does not believe the action is legally sound and will pursue legal action against the move.
  • The company has apologized for a leaked internal memo that criticized US President Donald Trump.

Read also: Market Analysis: Key Stocks to Watch - Narayana Hrudayalaya, ABB India, Federal Bank, Premier Energies, Ather Energy and More

Impact on Anthropic and Customers

  • The SCR designation only applies to the use of Claude, Anthropic's AI model, as part of contracts with the DoW and not to its use by customers for other purposes.
  • Individual customers and those with commercial contracts with Anthropic will not be affected.
  • DoW contractors may see their use of Claude restricted to DoW contract work, but will not be impacted for use related to other customers.

Company Response and Future Plans

  • Anthropic has stated that it will continue to provide its models to the national security community at nominal cost and with support from its engineers.
  • The company has committed to ensuring that national security experts are not deprived of important tools.
  • Anthropic will prioritize providing its models to the DoW and the national security community for as long as necessary and as long as permitted.

Read also: FirstClub Secures $55 Million in Funding from Peak XV, Sofina, and Other Investors 9 Months After $22 Million Series A Round

Investor Takeaway

Investors should be cautious of potential regulatory risks affecting AI companies.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.